These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 26093250)

  • 1. Stabilization of Protein-Protein Interactions in chemical biology and drug discovery.
    Bier D; Thiel P; Briels J; Ottmann C
    Prog Biophys Mol Biol; 2015 Oct; 119(1):10-9. PubMed ID: 26093250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stabilization of protein-protein interactions in drug discovery.
    Andrei SA; Sijbesma E; Hann M; Davis J; O'Mahony G; Perry MWD; Karawajczyk A; Eickhoff J; Brunsveld L; Doveston RG; Milroy LG; Ottmann C
    Expert Opin Drug Discov; 2017 Sep; 12(9):925-940. PubMed ID: 28695752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small-molecule stabilization of protein-protein interactions: an underestimated concept in drug discovery?
    Thiel P; Kaiser M; Ottmann C
    Angew Chem Int Ed Engl; 2012 Feb; 51(9):2012-8. PubMed ID: 22308055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Compound Classes: Protein-Protein Interactions.
    Ottmann C
    Handb Exp Pharmacol; 2016; 232():125-38. PubMed ID: 26489828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stabilization of protein-protein interactions by small molecules.
    Giordanetto F; Schäfer A; Ottmann C
    Drug Discov Today; 2014 Nov; 19(11):1812-1821. PubMed ID: 25173701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biophysical and computational fragment-based approaches to targeting protein-protein interactions: applications in structure-guided drug discovery.
    Winter A; Higueruelo AP; Marsh M; Sigurdardottir A; Pitt WR; Blundell TL
    Q Rev Biophys; 2012 Nov; 45(4):383-426. PubMed ID: 22971516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small-Molecule Stabilization of the 14-3-3/Gab2 Protein-Protein Interaction (PPI) Interface.
    Bier D; Bartel M; Sies K; Halbach S; Higuchi Y; Haranosono Y; Brummer T; Kato N; Ottmann C
    ChemMedChem; 2016 Apr; 11(8):911-8. PubMed ID: 26644359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of protein-protein interactions (PPIs): an analysis of scaffold choices and buried surface area.
    Ran X; Gestwicki JE
    Curr Opin Chem Biol; 2018 Jun; 44():75-86. PubMed ID: 29908451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the relationship between hub proteins and drug targets based on GO and intrinsic disorder.
    Fu Y; Guo Y; Wang Y; Luo J; Pu X; Li M; Zhang Z
    Comput Biol Chem; 2015 Jun; 56():41-8. PubMed ID: 25854804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational modulator design by exploitation of protein-protein complex structures.
    Wichapong K; Poelman H; Ercig B; Hrdinova J; Liu X; Lutgens E; Nicolaes GA
    Future Med Chem; 2019 May; 11(9):1015-1033. PubMed ID: 31141413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural products used as a chemical library for protein-protein interaction targeted drug discovery.
    Jin X; Lee K; Kim NH; Kim HS; Yook JI; Choi J; No KT
    J Mol Graph Model; 2018 Jan; 79():46-58. PubMed ID: 29136547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and screening of small-molecule α-helix mimetic libraries targeting protein-protein interactions.
    Moon H; Lim HS
    Curr Opin Chem Biol; 2015 Feb; 24():38-47. PubMed ID: 25461722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico structure-based approaches to discover protein-protein interaction-targeting drugs.
    Shin WH; Christoffer CW; Kihara D
    Methods; 2017 Dec; 131():22-32. PubMed ID: 28802714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AlphaSpace: Fragment-Centric Topographical Mapping To Target Protein-Protein Interaction Interfaces.
    Rooklin D; Wang C; Katigbak J; Arora PS; Zhang Y
    J Chem Inf Model; 2015 Aug; 55(8):1585-99. PubMed ID: 26225450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stabilization of protein-protein interaction complexes through small molecules.
    Zarzycka B; Kuenemann MA; Miteva MA; Nicolaes GAF; Vriend G; Sperandio O
    Drug Discov Today; 2016 Jan; 21(1):48-57. PubMed ID: 26434617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helix mimetics: Recent developments.
    Wilson AJ
    Prog Biophys Mol Biol; 2015 Oct; 119(1):33-40. PubMed ID: 26048776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges in Discovering Drugs That Target the Protein-Protein Interactions of Disordered Proteins.
    Oláh J; Szénási T; Lehotzky A; Norris V; Ovádi J
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein-protein interactions as drug targets.
    Skwarczynska M; Ottmann C
    Future Med Chem; 2015; 7(16):2195-219. PubMed ID: 26510391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interfering peptides targeting protein-protein interactions: the next generation of drugs?
    Bruzzoni-Giovanelli H; Alezra V; Wolff N; Dong CZ; Tuffery P; Rebollo A
    Drug Discov Today; 2018 Feb; 23(2):272-285. PubMed ID: 29097277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of Drug-Like Protein-Protein Interaction Stabilizers Guided By Chelation-Controlled Bioactive Conformation Stabilization.
    Bosica F; Andrei SA; Neves JF; Brandt P; Gunnarsson A; Landrieu I; Ottmann C; O'Mahony G
    Chemistry; 2020 Jun; 26(31):7131-7139. PubMed ID: 32255539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.